// App-Quantinova.ai

FRI0299 (2017) : N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE (NT-PROBNP) LEVEL IN PATIENTS WITH UNTREATED SYSTEMIC LUPUS ERYTHEMATOSUS

Researchers

Presenter

  • T. Panafidina

Principal Investigators

  • M. Sokhova

  • T. Popkova

  • D. Novikova

  • E. Alexandrova

  • E. Nasonov

Medical Centers

  • VA Nasonova Institute of Rheumatology, Moscow, Russian Federation, Moscow, Russia

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • C reactive protein

  • Interleukin 6

  • N-terminal pro b-type natriuretic peptide

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

  • Prednisone

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved